Illumina appointed former NHGRI director Eric Green as chief medical officer, a strategic hire as the sequencing leader pivots toward clinical applications and healthcare integration. Green will join Illumina in February and is expected to help drive the company’s push into clinical genomics and multiomics product strategies. In interviews Green said he plans to advocate for genomics in clinical care and help Illumina translate research‑grade assays into validated clinical workflows. The hire closes a long‑vacant CMO role and signals Illumina’s intent to lean into regulatory, clinical adoption and payer engagement as laboratories and health systems scale comprehensive genomic profiling.